ID
22587
Description
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Keywords
Versions (3)
- 6/8/17 6/8/17 -
- 6/8/17 6/8/17 -
- 6/8/17 6/8/17 -
Copyright Holder
Genentech, Inc.
Uploaded on
June 8, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
INVESTIGATOR / SITE INFORMATION (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330
INVESTIGATOR / SITE INFORMATION (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330
Similar models
INVESTIGATOR / SITE INFORMATION (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330
C2986440 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])